Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Fortis investors move...

    Fortis investors move SEBI over delay in IHH open offer, ask for interest: Report

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2019-05-23T17:22:10+05:30  |  Updated On 18 Oct 2021 3:58 PM IST

    New Delhi: Displeased with delay in an open offer to buy an additional stake, a few of the shareowners holding minor shares of Fortis Healthcare Ltd (FHL) have reportedly reached out to the country's market regulator. According to a recent media report, a group of minority shareholders have urged the Securities and Exchange Board of India (SEBI) to issue directions to Malaysian firm IHH Healthcare Bhd to pay interest to shareholders for a delay in the open offer to buy an additional 26% stake in Fortis Healthcare.


    The shareholders have requested SEBI to issue directions to IHH Healthcare to ensure the early continuation of the open offer tendering process, two people aware of the matter told Live Mint.


    As per the shareholders, the claim for interest is justified as minority shareholders have been deprived of the open offer dues for a long time. They further held IHH Healthcare responsible for not taking adequate steps to become a party to the case for seeking restart of the open offer.


    The offer was to open for subscription from 18 December till 1 January. However, IHH Healthcare could not proceed with the open offer following a Supreme Court's order to put the transaction on hold, following a contempt plea moved by Japanese drug maker Daiichi Sankyo Co. Ltd against the Singh brothers, the former promoters of Fortis.


    Medical Dialogues had earlier reported that the apex court had refused to pass any interim order on pleas relating to the sale of controlling stakes of Fortis Healthcare to Malaysian IHH Healthcare Berhad by former Ranbaxy promoters and hospital operators Malvinder and Shivinder Singh.




    However, regulation 18 (11) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, says that the "acquirer shall be responsible to pursue all statutory approvals required by the acquirer in order to complete the open offer without any delay, neglect or delay".


    The Supreme Court had in December put on hold the Fortis-IHH deal. Thereafter, the IHH, in its regulatory filing, said it will not be able to go ahead with the open offer for Fortis Healthcare for the time being. However, more than five months later the situation remains the same.


    IHH chief executive officer Tan See Leng told reporters in March, "We at IHH fully respect and (have the) highest regard for the Indian judiciary process...we certainly, hope India will support foreign investors as well as minority shareholders in Fortis to have their chance to realise the value of their investment through this open offer, which till now has been delayed."


    In the current scenario, shareholders hold that Sebi should protect the interest of investors. "As a regulator, Sebi can become a party to the case in the Supreme Court for the limited purpose of seeking resumption of the open offer so that shareholders are able to avail the much-delayed open offer opportunity," the first person mentioned above told Live Mint.


    While Shriram Subramanian, founder and managing director of proxy firm InGovern Research said, "As the open offer process has been stopped by the Supreme Court itself, there may be a case for minority investors to seek compensation in the form of interest for the delay in the open offer process."


    Sources told Live Mint that IHH Healthcare has acquired the hospital chain and has not done enough for shareholders to realize the value of their investment through the open offer.


    In July 2018, IHH Healthcare won a bidding war to acquire Fortis and completed the deal in November, buying a 31.1% stake through preferential allotment of shares.

    daiichiDaiichi SankyoFHLFortisFortis HealthcareFortis Healthcare LtdFortis ihh dealfortis minority shareholdersFortis open offerfortis shareholderFortis sharesHealthcarehospitalIHHIHH HealthcareIHH Healthcare BhdIngovern ResearchJapanese firm Daiichi SankyoMalaysian firmMalaysian IHH HealthcareMalvinderRanbaxySCSEBIShivinder SinghSingh brothersSupreme CourtSEBIShivinder SinghSingh brothersSupreme Court
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok